Chun-Yan Yeung

Chun-Yan Yeung

Auto-generated profile, based on publicly available information

Chun-Yan Yeung

Department of Medicine, Mackay Medical College, New Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
WCWai-Tao Chan
Wai-Tao Chan
CLCheng-Che Liu
Cheng-Che Liu
JCJen-Shiu Chiang Chiau
Jen-Shiu Chiang Chiau
STShang-Ting Tsai
Shang-Ting Tsai
CLChih-Kai Liang
Chih-Kai Liang
SHShao-Yi Hou
Shao-Yi Hou
Silica nanoparticles (SiNPs) are being studied and used for medical purposes. As nanotechnology grows rapidly, its biosafety and toxicity have frequently raised concerns. However, diverse results have been reported about the safety of SiNPs; several studies reported that smaller particles might exhibit toxic effects to some cell lines, and larger particles of 100 nm were reported to be genotoxic to the cocultured cells. Here, we investigated the in vivo toxicity of SiNPs of 150 nm in various dosages via intravenous administration in mice. The mice were observed for 14 days before blood examination and histopathological assay. All the mice survived and behaved normally after the administration of nanoparticles. No significant weight change was noted. Blood examinations showed no definite systemic dysfunction of organ systems. Histopathological studies of vital organs confirmed no SiNP-related adverse effects. We concluded that 150 nm SiNPs were biocompatible and safe for in vivo use in mice.

8 September 2025 in Interactive Journal of Medical Research
Verified
Journal Article
Open access
SWShun-Long Weng
Shun-Long Weng
FHFang-Yu Hung
Fang-Yu Hung
SLSung-Tse Li
Sung-Tse Li
BLBo-Huang Liou
Bo-Huang Liou
CYChun-Yan Yeung
Chun-Yan Yeung
Chien-Yu LinChien-Yu Lin
Chien-Yu Lin
Background: Dengue fever remains the most significant vector-borne disease in Southeast Asia, imposing a substantial burden on public health systems. Global warming and increased international mobility may exacerbate the disease’s prevalence. Furthermore, the unprecedented COVID-19 pandemic may have influenced the epidemiological patterns of dengue. Objective: This study aimed to evaluate epidemiological changes in dengue incidence in Southeast Asia. Methods: We conducted a retrospective, multicountry ecological study analyzing trends in dengue incidence in 7 Southeast Asian countries from January 2000 to December 2023. Data were extracted from official World Health Organization reports and national health department databases. Countries with data that were incomplete, inconsistent, or not publicly available were excluded from the final analysis. Annual incidence rates were analyzed, and linear trends were calculated to assess long-term patterns. Results: Epidemiological data from 7 Southeast Asian countries, comprising Thailand, Singapore, Vietnam, Malaysia, the Philippines, Cambodia, and Taiwan, were analyzed across the 24-year study period. A notable nadir in dengue cases was observed coinciding with the COVID-19 pandemic. Significant increasing trends in dengue incidence were identified in Singapore, Vietnam, Malaysia, and the Philippines (slopes: 8.243, 6.513, 8.737, and 8.172; R 2 values: 0.14, 0.34, 0.345, and 0.46, respectively, all P <.05). Conclusions: Dengue fever continues to pose a significant public health challenge in Southeast Asia. Our analysis demonstrates a substantial increase in dengue cases in several countries over the study period. While a temporary decline was observed during the COVID-19 pandemic, a subsequent resurgence of cases highlights the persistent threat of dengue in the region. These findings underscore the critical need for sustained surveillance and innovative control strategies to mitigate the impact of dengue in Southeast Asia.